Company / Operating Income per Share
Sana Biotechnology, Inc. Operating Income per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.18
FY2024
5-year range
-$21.99 / -$1.18
FY2020-FY2024
Trend
+21.6%
vs FY2023
Sector context
#92 of 201
Health Care
What the data says
At $-1.18, Sana Biotechnology, Inc.'s operating income per share ranks #92 of 201 in the Health Care sector. Improved from $-1.45 to $-1.18 over the past 2 years.
Based on SEC 10-K filings.
-1.18 in FY2024.
Improved from $-1.45 to $-1.18 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 201 in Health CareTop 46% of 201This company -$1.18 Sector average -$28.56
▼
+95.9% above sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 21.6% year-over-year.
- Ranks #92 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.18 | +21.6% |
| FY2023 | -$1.51 | -4.1% |
| FY2022 | -$1.45 | +32.5% |
| FY2021 | -$2.14 | +90.2% |
| FY2020 | -$21.99 | +23.6% |
| FY2019 | -$28.79 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026